GSK boosts pipeline with USD2.2 billion purchase of RAPT Therapeutics
(Alliance News) - GSK PLC on Tuesday announced the USD2.2 billion acquisition of RAPT Therapeutics Inc, a California-based clinical-stage biopharmaceutical company focused on novel therapies for inflammatory and immunologic diseases. Read More